Perspectives
Published Editorials and Industry Updates
Welcome to Perspectives, our blog designed to keep members, oncology stakeholders, and anyone interested in enhancing the care experience for oncology patients informed on critical issues. You’ll hear from thought leaders and learn about the impact and benefits of medically integrated pharmacy, operational insights designed to support you in the day-to-day delivery of care, as well as timely industry issues facing oncology pharmacy professionals.
Virginia Cancer Specialists Earns Full Accreditation from NCODA’s Center of Excellence Medically Integrated Pharmacy Program
December 5, 2024
Congratulations to NCODA member practice Virginia Cancer Specialists on their recent Center of Excellence MIP Accreditation! Virginia Cancer Specialists’ full accreditation offers a win-win for patients as well as practices, providers, employers, payers, and pharmaceutical companies, as it facilitates faster access of oncolytics to patients, improvement in medical adherence, reduced waste due to cost avoidance, […]
read more
Unlocking the Potential of Patient Navigation: New CPT Codes Pave the Way for Enhanced Oncology Care
November 20, 2024
The landscape of oncology care is evolving rapidly, driven by the need for more personalized, patient-centered approaches. In alignment with the Biden-Harris Cancer Moonshot initiative to provide equitable access to care, the Centers for Medicare & Medicaid Services (CMS) has introduced new CPT codes for reimbursing patient navigation services, effective January 1, 2024. These codes […]
read more
Pharmaceutical Famine
November 20, 2024
The oncology community faces a mounting crisis as essential chemotherapy drugs become alarmingly scarce across hospitals and clinics nationwide. This shortage gravely threatens cancer patients who rely on timely and effective chemotherapy, a crucial determinant of treatment success. For many patients, access to these medications means the difference between life and death, underscoring the urgency […]
read more
Biosimilar Drama: Navigating Medicare’s Changing Landscape
October 30, 2024
Author: Natasha Olson, PharmD | Senior Manager of Clinical Communications & Outreach, NCODA The introduction of biosimilars and 505(b)(2) generics in oncology has been a game-changer for patients and practices alike. By offering cost-effective alternatives to high-priced branded biologics, these new treatments are poised to make cancer care more accessible and affordable. For the pharmaceutical […]
read more
Understanding Medicare’s 2025 Reforms: Key Impacts on Oncology Practices
October 30, 2024
Author: NCODA Editorial Team As we look ahead to 2025, significant changes to Medicare are set to bring much-needed relief to millions of Americans, particularly those facing the high costs of life-saving medications. With the introduction of a $2,000 out-of-pocket cap for prescription drugs under Medicare Part D and the new Medicare Prescription Payment Plan, […]
read more
NCODA Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) Accreditation – Total Patient Management
October 16, 2024
If you’ve read the first two articles in our series about our recent posts on the NCODA CoE MIP Accreditation program, you know it promotes a fully integrated team approach to patient care, leveraging the electronic health record (EHR) at every stage of the patient journey. This ensures total patient management, including clinical assessments, lab […]
read more
NCODA Medically Integrated Pharmacy CoE Accreditation – Differentiation with a Commitment to Comprehensive Patient Onboarding
September 26, 2024
In this second article of our accreditation series, we highlight how NCODA’s Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) Accreditation standards actively support the comprehensive patient onboarding process, ensuring that each patient receives personalized and coordinated care from the very start of their treatment journey. NCODA CoE standards promote a comprehensive onboarding process, where […]
read more
Design of Limited Distribution Networks (LDNs)
September 24, 2024
The distribution of oncology and hematology medications is complex and highly regulated, involving multiple stakeholders such as manufacturers, distributors, pharmacies, and healthcare providers. One of the most critical aspects of specialty distribution is the use of Limited Distribution Networks (LDNs), which are networks utilized by pharmaceutical manufacturers to control the distribution of specialty medications, including […]
read more
The Trials of Clinical Trials
September 24, 2024
In the rapidly advancing field of oncology, clinical trials are pivotal for the development of new and effective treatments. A critical component of these trials is the meticulous collection, recording, and verification of data, which is essential to demonstrate the safety and efficacy of novel therapies. However, the current landscape of data management in clinical […]
read more
The Distinctive Edge of NCODA’s Medically Integrated Oncology Pharmacy Accreditation
September 12, 2024
Imagine a pharmacy system that not only streamlines medication dispensing but also elevates patient care to unprecedented heights. This is the foundation of NCODA’s Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) Accreditation. As the first and only accreditation specifically designed for medically integrated pharmacies, the NCODA CoE MIP Accreditation program sets a new standard in patient-centered […]
read more
Uncovering Nuances in Equitable Oncology Care: Working Collaboratively to Address Key Issues
August 13, 2024
Cancer care has advanced significantly over the past few decades, with remarkable strides in diagnosis, treatment, and survivorship. However, these advances have not been equitably distributed across all populations. Cancer care in America is significantly influenced by various social determinants of health and access to care. Understanding how these factors impact equitable care is crucial […]
read more
Operationalizing the Delivery of Equitable Care in Oncology: Ways the Medically Integrated Team Partners Closely to Address Gaps
July 17, 2024
In the dynamic field of oncology, ensuring equitable care is paramount. Equitable care means providing all patients with fair access to high-quality healthcare, regardless of their socioeconomic status, race, or geographical location. Achieving this ideal is challenging due to systemic barriers and disparities that persist in the healthcare system. The commitment to equitable care requires […]
read more
RESOURCES
Cost Avoidance Waste Tracker
Positive Quality Interventions
PQI in Action
OCE Sheets
IVE Sheets
Treatment Support Kits
PQI Podcast
Members
Member Resources
OPTA
Committees
Member Login
Events
Webinars
Spring Forum
Oncology Institute
PSO Annual Meeting
Fall Summit
contact@ncoda.org
315-655-4640
P.O. Box 468
Cazenovia, NY 13035
